Інструкція із застосування KADTRE
Зміст інструкції
- CADTRE “1000 mg + 880 U.I. effervescent granules”
- CADTRE can be used during breastfeeding, but your doctor must be informed by
CADTRE “1000 mg + 880 U.I. effervescent granules”
30 sachets of effervescent granules
Calcium carbonate and Vitamin D3
Read this leaflet carefully before taking this medicine as it contains important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist (see section 4).
- See your doctor if you do not feel better or if you feel worse.
Contents of this leaflet:
- 1.What CADTRE is and what it is used for
- 2.What you need to know before you take CADTRE
- 3.How to take CADTRE
- 4.Possible side effects
- 5.How to store CADTRE
- 6.Contents of the pack and other information
1. What is CADTRE and what is it used for
CADTRE contains the active substances Calcium carbonate and Vitamin D3. Calcium is an important
constituent of bones and Vitamin D3 promotes the absorption of Calcium in the intestine and its
deposition in the bones.
It is used:
- In the correction of concomitant Vitamin D3 and Calcium deficiency states in elderly subjects
- As a supplement of Vitamin D3 and Calcium during specific therapies for the treatment of osteoporosis in subjects with ascertained Calcium and Vitamin D3 deficiency or at high risk.
2. What you need to know before using CADTRE
Do not use CADTRE if:
- if you are allergic to Calcium, Vitamin D3 or any of the other ingredients of this medicine (listed in section 6)
- if you suffer from diseases and/or are subject to conditions that can lead to a high concentration of calcium in the urine (hypercalciuria) or in the blood (hypercalcemia);
- if you are in a situation of prolonged immobilisation, especially if accompanied by high levels of calcium in the urine and/or blood (hypercalciuria and/or hypercalcemia
- if you are pregnant or breastfeeding (see section “Pregnancy, breastfeeding and fertility”)
- if you suffer from a pathological condition that leads to an accumulation of the amino acid phenylalanine (phenylketonuria)
- if you suffer from kidney stones (calcium oxalate lithiasis)
- and your kidneys are no longer able to perform their function correctly (renal insufficiency)
- .
Warnings and precautions
Consult your doctor or pharmacist before taking CADTRE:
- if your kidney function is impaired or if you have a tendency to form stones. Your treatment should be carefully monitored if your kidneys are not working properly to ensure sufficient calcium intake in your blood;
- if you suffer from an inflammatory disease of unidentified origin characterised by the formation of granulomas in various locations (sarcoidosis);
- if you are an immobilised patient suffering from osteoporosis;
- If you are taking calcium and alkalis from other sources (food, fortified foods or other medicinal products) If you are undergoing long-term treatment, your doctor may, from time to time, want to check the level of calcium in your blood and take a urine sample to monitor kidney function by measuring the amount of creatinine in the blood (serum creatinine). Based on the results, your doctor may reduce the dosage or decide to stop treatment. Children and adolescentsCADTRE is not intended for use in children. Other medicines and CADTREInform your doctor or pharmacist if you are taking or have recently taken or might take any other medicine. Consult your doctor if you are taking any of the following medicines:
- medicines for the heart, such as digoxin or other cardiac glycosides;
- medicines used to treat bone disorders such as bisphosphonate or sodium fluoride;
- medicines used to promote and increase urine production (thiazide diuretics);
- medicines used to treat epilepsy such as phenytoin or barbiturates;
- glucocorticosteroids;
- tetracycline antibiotics;
- other medicines containing vitamin D or calcium
- other medicines containing basic (alkaline) substances such as carbonate, as the concomitant intake with CADTRE may cause episodes of milk-alkali syndrome. Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently, iron, zinc or strontium ranelate preparations must be taken at least two hours before or after CADTRE. CADTRE with food, drinks and alcoholThis medicine may interact with certain foods containing oxalic acid (e.g. spinach and rhubarb), phosphates (e.g. bran) or phytic acid (e.g. whole grains), as these may reduce the absorption of calcium contained in CADTRE Pregnancy, breastfeeding and fertilityIf you are pregnant, suspect you are pregnant, are planning to become pregnant or are breastfeeding, ask your doctor for advice before taking this medicine. Due to the high content of Vitamin D, this dosage is not indicated during pregnancy and breastfeeding. In pregnant women, overdose of calcium and vitamin D should be avoided as persistent hypercalcemia is associated with adverse effects on fetal development.
CADTRE can be used during breastfeeding, but your doctor must be informed by
the time that calcium and vitamin D pass into breast milk. This must be taken into
consideration when administering vitamin D supplements to the baby.
Driving and operating machinery
CADTRE is not expected to affect the ability to drive or operate machinery.
CADTRE contains sodium and aspartameThis medicine contains less than 1 mmol of sodium (23
mg) per sachet, i.e. it is essentially “sodium-free”.
This medicine contains 40 mg of aspartame per sachet. Aspartame is a source of phenyl-
alanine. It may be harmful if you have phenylketonuria, a rare genetic disease that cau-
ses the accumulation of phenylalanine because the body cannot dispose of it correctly.
3. How to take CADTRE
Take this medicine following exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
Adults
Pour the contents of the sachet into a glass, add a large amount of water, stir and drink immediately after effervescence has ceased. The recommended dose is one sachet per day, preferably taken after meals.
Your doctor or pharmacist will tell you how many sachets to take per day.
If you take more CADTRE than you should
When an excessive dose of this medicine is taken, the following symptoms may appear: nausea, vomiting, intense thirst, increased need to urinate, constipation. If
any of these undesirable effects should occur, contact your doctor immediately and take the necessary precautionary measures.
If you forget to take CADTRE
Do not take a double dose to make up for a missed dose.
If you have any doubts about the use of this medicine, consult your doctor, pharmacist or
nurse.
4. Possible side effects
Like all medicines, CADTRE can cause side effects, although not everybody gets them.
manifest.
You may experience an allergic reaction. If you experience skin rash, itching,
difficulty breathing or swelling of the face, lips, throat or tongue, you should stop taking the
medicine immediately and seek urgent medical attention.
Uncommon (may affect up to 1 in 100 people)
- high calcium concentration in the blood (hypercalcemia). Symptoms include nausea, vomiting, loss of appetite, constipation, stomach pain, bone pain, extreme thirst, needing to urinate more often, muscle weakness, drowsiness and confusion;
- increased calcium content in the urine (hypercalciuria). Rare (may affect up to 1 in 1000)
- constipation, flatulence, nausea, abdominal pain, diarrhoea;
- itching, skin rash and urticaria. Not known (frequency cannot be estimated from available data)
- milk-alkali syndrome, associated with a high calcium concentration in the blood (hypercal- caemia), an elevated blood pH (alkalosis) and reduced or impaired kidney function (renal insufficiency).
- increased phosphate in the blood (hyperphosphataemia), kidney stones (nephrolithiasis), kidney damage due to an accumulation of calcium salts (nephrocalcinosis). This can occur in people who suffer from kidney problems.
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor, pharmacist or nurse. You can also report side effects directly through the national reporting system at
https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store CADTRE
Keep this medicine out of the reach and sight of children.
Do not use CADTRE after the expiry date stated on the packaging after exp.
The expiry date refers to the last day of that month.
Store at a temperature not exceeding 25°C and store in the original package to
protect the medicine from moisture.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What CADTRE contains
Each sachet contains
Active ingredients: Calcium carbonate 2500 mg (equivalent to 1000 mg of calcium) - Cholecalciferol (Vi-
tamin D3) 880 I.U.
The other ingredients are: citric acid, aspartame, sodium saccharin, orange flavour, maltode-
xtrin, yellow orange S.
Description of the appearance of CADTRE and contents of the pack
Effervescent granules. Pack of 30 sachets
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
NEW RESEARCH srl
Via Tiburtina n° 1143
00156 Rome
Manufacturer
LA.FA.RE. S.r.l.
Via Sac. Benedetto Cozzolino 77
80056 Ercolano - Naples
- Країна реєстрації
- Лікарська формаEffervescent granules, 1000 MG + 880 IU
- Потрібен рецептТак
- Виробник
- Ця інформація надана лише для ознайомлення і не є медичною порадою. Рішення щодо лікування завжди приймає лікар.
- Альтернативи до KADTREЛікарська форма: Coated tablet, 1000 MGДіюча речовина: Карбонат кальцияВиробник: THERAMEX IRELAND LIMITEDПотрібен рецептЛікарська форма: Injectable solution, 10 %Діюча речовина: глюконат кальцияВиробник: B. BRAUN MELSUNGEN AGПотрібен рецептЛікарська форма: Injectable solution, 500 MG/5 MLДіюча речовина: глюконат кальцияПотрібен рецепт
Аналоги KADTRE в інших країнах
Препарати з тією самою діючою речовиною, доступні в інших країнах.
Аналог KADTRE у Польща
Аналог KADTRE у Україна
Аналог KADTRE у Іспанія
Лікарі онлайн щодо KADTRE
Застосування, безпека та можливість призначення рецепта — за результатами медичної оцінки.
Отримайте рецепт на KADTRE онлайн
Заповніть форму за 2 хвилини
Розкажіть про симптоми, історію хвороби та потрібний препарат.
Оберіть лікаря або ми призначимо
Оберіть спеціаліста або ми підберемо найближчого доступного лікаря.
Лікар розглядає ваш випадок
Зазвичай протягом 30 хвилин. Може ставити уточнювальні запитання в чаті.
Отримайте в будь-якій аптеці
Електронний рецепт надсилається на вашу пошту — дійсний по всій Польщі.
Часті запитання
KADTRE потребує рецепта в Італія. Ви можете обговорити з лікарем онлайн, чи підходить цей лікарський засіб для вашої ситуації.
KADTRE виробляється компанією NEW RESEARCH S.R.L.. Назва бренду та упаковка можуть відрізнятися залежно від дистрибʼютора.
Лікарі, зокрема Сімейні лікарі, Психіатри, Дерматологи, Кардіологи, Ендокринологи, Гастроентерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Інфекціоністи, Алергологи, Геріатри, Педіатри, Онкологи, можуть оцінити доцільність застосування KADTRE з урахуванням вашого стану та місцевих правил. Ви можете записатися на онлайн-консультацію, щоб обговорити симптоми та можливі подальші кроки.
Польща має добре розвинену систему охорони здоров'я у великих містах, таких як Варшава, Краків, Вроцлав і Гданськ. Аптеки широко доступні та працюють відповідно до чинного законодавства, забезпечуючи доступ до рецептурних препаратів.
Ви можете придбати KADTRE у Варшаві, Кракові, Вроцлаві або Гданську в будь-якій аптеці за наявності дійсного рецепта.
Щоб отримати рецепт, ви можете скористатися Oladoctor:
Інші препарати з тією самою діючою речовиною () включають KAKIT, KALKIO LUKONATO B. BRAUN, KALKIO LUKONATO BIOINDUSTRIA L.I.M.. Вони можуть відрізнятися торговою назвою або формою випуску, але містять той самий терапевтичний компонент. Перед зміною або початком прийому нового препарату варто проконсультуватися з лікарем.
















